Roche Holding Ltd. (VTX:ROG) has been given a CHF 210 price target by investment analysts at HSBC Holdings plc in a research report issued on Monday. The brokerage currently has a “sell” rating on the healthcare company’s stock.

Several other analysts have also issued reports on the company. Goldman Sachs Group, Inc. (The) set a CHF 335 target price on Roche Holding and gave the stock a “buy” rating in a report on Friday, May 26th. Citigroup Inc. reiterated a “buy” rating on shares of Roche Holding in a report on Wednesday, July 5th. Morgan Stanley set a CHF 290 target price on Roche Holding and gave the stock a “buy” rating in a report on Monday, May 29th. Deutsche Bank AG set a CHF 273 target price on Roche Holding and gave the stock a “buy” rating in a report on Tuesday, June 6th. Finally, Societe Generale set a CHF 275 target price on Roche Holding and gave the stock a “neutral” rating in a report on Thursday, June 29th. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating and eight have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average target price of CHF 267.53.

Roche Holding (VTX:ROG) opened at 243.20 on Monday. Roche Holding has a one year low of CHK 218.30 and a one year high of CHK 273.00. The stock’s 50 day moving average price is CHK 243.57 and its 200-day moving average price is CHK 252.42. The firm has a market cap of CHK 207.51 billion and a price-to-earnings ratio of 21.59.

COPYRIGHT VIOLATION WARNING: “HSBC Holdings plc Analysts Give Roche Holding Ltd. (ROG) a CHF 210 Price Target” was originally posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this article on another site, it was copied illegally and reposted in violation of U.S. & international copyright laws. The correct version of this article can be accessed at https://www.thecerbatgem.com/2017/09/18/hsbc-holdings-plc-analysts-give-roche-holding-ltd-rog-a-chf-210-price-target.html.

Roche Holding Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company’s operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics.

Analyst Recommendations for Roche Holding (VTX:ROG)

Receive News & Stock Ratings for Roche Holding Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche Holding Ltd. and related stocks with our FREE daily email newsletter.